We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,809 results
  1. Real-World Evidence to Support the Registration of a New Osteoporosis Medicinal Product in Europe

    Real-World Evidence (RWE), which has historically been used to support post-approval safety studies, has recently gained acceptance for new drug...

    Colleen Davenport, Patricia Gravel, ... Bruce Mitlak in Therapeutic Innovation & Regulatory Science
    Article Open access 10 February 2024
  2. Effect of Ellipticine in Glucocorticoid-Induced Osteoporosis: In Silico and In Vivo Analyses

    Glucocorticoids cause secondary osteoporosis, which leads to considerable morbidity from fractures. The antiosteoporosis activity of ellipticine...

    Yan Zhang, **g Wang in Revista Brasileira de Farmacognosia
    Article 16 March 2023
  3. Revisiting Ipriflavone: a Potential Isoflavone for the Management of Postmenopausal Osteoporosis

    Ipriflavone is a nutraceutical extensively used in Asian countries since 1890 for postmenopausal osteoporosis as a phytoestrogen to inhibit bone...

    Anish John, Anoop Narayanan V, Kiran Konkodi in Revista Brasileira de Farmacognosia
    Article 13 October 2021
  4. Anti-osteoporosis effects of triterpenoids from the fruit of sea buckthorn (Hippophae rhamnoides) through the promotion of osteoblast differentiation in mesenchymal stem cells, C3H10T1/2

    In a previous study, we discovered that the ethanolic extract of sea buckthorn ( Hippophae rhamnoides ) fruits exhibited anti-osteoporosis effects both...

    Da Eun Lee, Kun Hee Park, ... Ki Hyun Kim in Archives of Pharmacal Research
    Article 26 September 2023
  5. A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China

    On June 23, 2020, Prolia ® (denosumab) was approved by the National Medical Products Administration (NMPA) in the People’s Republic of China as the...

    Neal E. Storm, Wen Chang, ... Steven K. Galson in Therapeutic Innovation & Regulatory Science
    Article Open access 11 October 2021
  6. Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models

    Background

    Mice lacking either colony-stimulating factor-1 (CSF-1) or its receptor, CSF-1R, display osteopetrosis. Accordingly, genetic deletion or...

    Arisaí Martínez-Martínez, Enriqueta Muñoz-Islas, ... Juan M. Jiménez-Andrade in Pharmacological Reports
    Article 28 March 2020
  7. Artemether Inhibits RANKL-Induced Osteoclast Differentiation and Prevents Bone Loss in Ovariectomized Mice

    Bone homeostasis is dynamically balanced by osteoclastic bone resorption and osteoblastic bone formation. Increased numbers and enhanced activities...

    Ming-Xuan Feng, Zhao-Bo Zhang, ... **ao Teng in Revista Brasileira de Farmacognosia
    Article 12 June 2023
  8. Effects of phytoestrogens on reproductive organ health

    Phytoestrogens are non-steroidal, polyphenolic compounds that are derived from plants and have biological properties similar to those of human...

    S. Swathi Krishna, Beena Briget Kuriakose, P. K. Lakshmi in Archives of Pharmacal Research
    Article 28 November 2022
  9. Spectrophotometric Determination of Sodium Prodronate in Tablets for Osteoporosis Treatment

    A spectrophotometric method for determining sodium prodronate in tablets by measuring the absorption at 237 ± 2 nm of a Cu(II)—prodronate complex in...

    D. M. Bulyga, O. P. Popova, ... D. V. Lopatik in Pharmaceutical Chemistry Journal
    Article 05 December 2019
  10. Phytoestrogenic Potential of Resveratrol by Selective Activation of Estrogen Receptor-α in Osteoblast Cells

    Resveratrol obtained in grape seed and skin is structurally similar to a synthetic estrogen diethylstilbestrol. The endogenous estrogen,...

    Aarti Abhishek Shah, Abhishek Shah, ... Yogendra Nayak in Revista Brasileira de Farmacognosia
    Article Open access 17 March 2022
  11. Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics

    Atractylodes macrocephala Koidz is a widely used as a traditional Chinese medicine. Atractylenolides (-I, -II, and -III) are a class of lactone...

    Mao Deng, Huijuan Chen, ... **aofang Li in Archives of Pharmacal Research
    Article 16 July 2021
  12. Organ-Based Medicine

    The core problem of both medicine and all biomedical research, which would also exist if all research had become reproducible, statistically correct,...
    Chapter 2022
  13. Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives

    Sophora is deemed as one of the most remarkable genera of Fabaceae, and the third largest family of flowering plants. The genus Sophora comprises...

    Howaida I. Abd-Alla, Dalila Souguir, Mohamed O. Radwan in Archives of Pharmacal Research
    Article 01 November 2021
  14. Women’s Health from a Pharmacy Perspective

    This chapter looks specifically at the available pharmacist services based evidence in relation to women’s health across the life course. Women’s...
    Reference work entry 2023
  15. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review

    Cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes involved in the biosynthesis and degradation of the...

    Gidion Wilson, Lingling Yang, ... Xueqin Ma in Pharmacological Reports
    Article 31 October 2023
  16. Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework

    While industry and regulators’ interest in decentralized clinical trials (DCTs) is long-standing, the Covid-19 pandemic accelerated and broadened the...

    Rima Izem, Emmanuel Zuber, ... Robert Hemmings in Therapeutic Innovation & Regulatory Science
    Article 05 February 2024
  17. Effect of Cinnamon and Aconite on Bone Formation-Bone Absorption Coupling in Bone Microenvironment

    Aconite and cinnamon can treat many diseases. The study aimed to assess the effectiveness and mechanism of aconite, cinnamon, and aconite-cinnamon in...

    Li** Yao, Qiaoyan Zhang, ... Lu Zhang in Revista Brasileira de Farmacognosia
    Article 28 December 2023
  18. Manage osteoporotic pain by treating osteoporosis and taking a multidimensional approach to pain management

    Although osteoporosis is referred as a silent disease due to its asymptomatic nature, many patients experience pain from osteoporosis-related...

    Article 27 March 2018
  19. Recent advances in GPR35 pharmacology; 5-HIAA serotonin metabolite becomes a ligand

    GPR35, an orphan receptor, has been waiting for its ligand since its cloning in 1998. Many endogenous and exogenous molecules have been suggested to...

    Article 25 May 2023
  20. The potential health benefits of the isoflavone glycoside genistin

    Genistin is a type of isoflavone glycoside and has a broad range of health benefits. It is found in a variety of dietary plants, such as soybean,...

    Anowarul Islam, Md Sadikul Islam, ... Md Rashedunnabi Akanda in Archives of Pharmacal Research
    Article 07 April 2020
Did you find what you were looking for? Share feedback.